Reuters logo
BRIEF-Abbvie says new data finds Imbruvica may offer more targeted approach to CLL treatment
June 5, 2017 / 11:21 AM / 6 months ago

BRIEF-Abbvie says new data finds Imbruvica may offer more targeted approach to CLL treatment

June 5 (Reuters) - AbbVie Inc:

* New data presented at ASCO 2017 finds Imbruvica may offer more targeted approach to CLL treatment than chemotherapy agent Chlorambucil in treatment-naïve patients​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below